These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25889060)

  • 1. Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity.
    Parra-Salcedo F; Contreras-Yáñez I; Elías-López D; Aguilar-Salinas CA; Pascual-Ramos V
    Arthritis Res Ther; 2015 Feb; 17(1):34. PubMed ID: 25889060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs.
    Sánchez T; Contreras-Yáñez I; Elías-López D; Aguilar Salinas CA; Pascual-Ramos V
    Clin Exp Rheumatol; 2014; 32(4):509-15. PubMed ID: 25005131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era.
    Galicia-Hernández G; Parra-Salcedo F; Ugarte-Martínez P; Contreras-Yáñez I; Ponce-de-León A; Pascual-Ramos V
    Clin Exp Rheumatol; 2016; 34(2):261-9. PubMed ID: 26939612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early disease activity suppression and younger age predict excellent outcome of recent-onset rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs.
    Contreras-Yáñez I; Rull-Gabayet M; Pascual-Ramos V
    Clin Exp Rheumatol; 2012; 30(3):402-8. PubMed ID: 22510514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs.
    Contreras-Yáñez I; Rull-Gabayet M; Vázquez-Lamadrid J; Pascual-Ramos V
    Eur J Radiol; 2011 Aug; 79(2):e52-7. PubMed ID: 21477956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cárdenas-de la Garza JA; Vera-Pineda R; Wah-Suárez M; Arvizu-Rivera RI; Martínez-Moreno A; Ramos-Cázares RE; Torres-Quintanilla FJ; Valdovinos-Bañuelos A; Esquivel-Valerio JA; Garza-Elizondo MA
    Rheumatol Int; 2017 Sep; 37(9):1507-1511. PubMed ID: 28681250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study.
    Šalamon L; Morović-Vergles J; Marasović-Krstulović D; Kehler T; Šakić D; Badovinac O; Vlak T; Novak S; Štiglić-Rogoznica N; Hanih M; Bedeković D; Grazio S; Kadojić M; Milas-Ahić J; Prus V; Stamenković D; Šošo D; Anić B; Babić-Naglić Ð; Gamulin S
    Rheumatol Int; 2015 Dec; 35(12):2047-57. PubMed ID: 26059944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis.
    Sahebari M; Goshayeshi L; Mirfeizi Z; Rezaieyazdi Z; Hatef MR; Ghayour-Mobarhan M; Akhlaghi S; Sahebkar A; Ferns GA
    ScientificWorldJournal; 2011 Jun; 11():1195-205. PubMed ID: 21666989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
    Karvounaris SA; Sidiropoulos PI; Papadakis JA; Spanakis EK; Bertsias GK; Kritikos HD; Ganotakis ES; Boumpas DT
    Ann Rheum Dis; 2007 Jan; 66(1):28-33. PubMed ID: 16793841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.
    Schulman E; Bartlett SJ; Schieir O; Andersen KM; Boire G; Pope JE; Hitchon C; Jamal S; Thorne JC; Tin D; Keystone EC; Haraoui B; Goodman SM; Bykerk VP;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1185-1191. PubMed ID: 29193840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters.
    Contreras-Yáñez I; Pascual-Ramos V
    Arthritis Res Ther; 2015 Jul; 17(1):177. PubMed ID: 26162892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity.
    Gomes KWP; Luz AJP; Felipe MRB; Beltrão LA; Sampaio AXC; Rodrigues CEM
    Mod Rheumatol; 2018 Mar; 28(2):258-263. PubMed ID: 28486047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal metabolic rate and Charlson Comorbidity Index are independent predictors of metabolic syndrome in patients with rheumatoid arthritis.
    Xu H; Choi SE; Kang JK; Park DJ; Lee JK; Lee SS
    Joint Bone Spine; 2020 Oct; 87(5):455-460. PubMed ID: 32278813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.
    Abourazzak FE; Mansouri S; Najdi A; Tahiri L; Nejjari C; Harzy T
    Clin Rheumatol; 2014 Nov; 33(11):1549-55. PubMed ID: 24647982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
    Toms TE; Panoulas VF; John H; Douglas KM; Kitas GD
    Arthritis Res Ther; 2009; 11(4):R110. PubMed ID: 19607680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.